Maged Shenouda - Net Worth and Insider Trading
Maged Shenouda Net Worth
The estimated net worth of Maged Shenouda is at least $33,838 dollars as of 2024-12-29. Maged Shenouda is the CFO of Relmada Therapeutics Inc and owns about 88,335 shares of Relmada Therapeutics Inc (RLMD) stock worth over $33,832. Maged Shenouda is also the CHIEF FINANCIAL OFFICER of Entero Therapeutics Inc and owns about 10 shares of Entero Therapeutics Inc (ENTO) stock worth over $6. Details can be seen in Maged Shenouda's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Maged Shenouda has not made any transactions after 2024-09-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Maged Shenouda
Maged Shenouda Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Maged Shenouda owns 2 companies in total, including Relmada Therapeutics Inc (RLMD) , and Entero Therapeutics Inc (ENTO) .
Click here to see the complete history of Maged Shenouda’s form 4 insider trades.
Insider Ownership Summary of Maged Shenouda
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RLMD | Relmada Therapeutics Inc | 2024-09-11 | director |
| ENTO | Entero Therapeutics Inc | 2018-12-28 | director |
Maged Shenouda Latest Holdings Summary
Maged Shenouda currently owns a total of 2 stocks. Among these stocks, Maged Shenouda owns 88,335 shares of Relmada Therapeutics Inc (RLMD) as of September 11, 2024, with a value of $33,832 and a weighting of 99.98%. Maged Shenouda also owns 10 shares of Entero Therapeutics Inc (ENTO) as of December 28, 2018, with a value of $6 and a weighting of 0.02%.
Latest Holdings of Maged Shenouda
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RLMD | Relmada Therapeutics Inc | 2024-09-11 | 88,335 | 0.38 | 33,832 |
| ENTO | Entero Therapeutics Inc | 2018-12-28 | 10 | 0.60 | 6 |
Holding Weightings of Maged Shenouda
Maged Shenouda Form 4 Trading Tracker
According to the SEC Form 4 filings, Maged Shenouda has made a total of 9 transactions in Relmada Therapeutics Inc (RLMD) over the past 5 years, including 2 buys and 7 sells. The most-recent trade in Relmada Therapeutics Inc is the acquisition of 53,432 shares on September 11, 2024, which cost Maged Shenouda around $149,610.
According to the SEC Form 4 filings, Maged Shenouda has made a total of 0 transactions in Entero Therapeutics Inc (ENTO) over the past 5 years. The most-recent trade in Entero Therapeutics Inc is the acquisition of 3 shares on December 28, 2018, which cost Maged Shenouda around $26,200.
Insider Trading History of Maged Shenouda
- 1
Maged Shenouda Trading Performance
GuruFocus tracks the stock performance after each of Maged Shenouda's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Maged Shenouda is -13.67%. GuruFocus also compares Maged Shenouda's trading performance to market benchmark return within the same time period. The performance of stocks bought by Maged Shenouda within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Maged Shenouda's insider trading performs compared to the benchmark.
Performance of Maged Shenouda
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.11 | | | | | |
| Relative Return to S&P 500(%) | 10.88 | | | | | |
Maged Shenouda Ownership Network
Maged Shenouda Owned Company Details
What does Relmada Therapeutics Inc do?
Who are the key executives at Relmada Therapeutics Inc?
Maged Shenouda is the director of Relmada Therapeutics Inc. Other key executives at Relmada Therapeutics Inc include director & Chief Executive Officer Sergio Traversa , Chief Financial Officer Chuck Ence , and Chief Medical Officer Cedric O'gorman .
Relmada Therapeutics Inc (RLMD) Insider Trades Summary
Over the past 18 months, Maged Shenouda made 2 insider transaction in Relmada Therapeutics Inc (RLMD) with a net purchase of 86,107. Other recent insider transactions involving Relmada Therapeutics Inc (RLMD) include a net purchase of 240,000 shares made by Sergio Traversa , a net purchase of 38,970 shares made by Chuck Ence , and a net purchase of 25,000 shares made by Paul Edward Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Relmada Therapeutics Inc (RLMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Relmada Therapeutics Inc (RLMD) were sold and 403,077 shares were bought by its insiders, resulting in a net purchase of 403,077 shares.
Relmada Therapeutics Inc (RLMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Relmada Therapeutics Inc Insider Transactions
Maged Shenouda Mailing Address
Above is the net worth, insider trading, and ownership report for Maged Shenouda. You might contact Maged Shenouda via mailing address: 305 West 18th Street, Apt 4b, New York Ny 10011.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
